Author

Jianming Wu

University of MinnesotaORCID 0000-0002-6136-7469Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anders J. LindstedtiD· 1 shared Anders W. MatsoniD· 1 shared Bruce K. WalcheckiD· 1 shared Emily Nestor TruckenbrodiD· 1 shared Jeffrey S. MilleriD· 1 shared Kate J. DixoniD· 1 shared Martin FelicesiD· 1 shared Robert Hullsiek· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anders J. LindstedtORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Anders W. Matson, Robert Hullsiek, Kate J. Dixon, Sam C. Wang, Anders J. Lindstedt, Ryan R. Friess, Shee Kwan Phung, Tanya S. Freedman, Martin Felices, Emily Nestor Truckenbrod, Jianming Wu, Jeffrey S. Miller, Bruce K. Walcheck

This study shows that an ADAM17-blocking antibody enhances IL-15-mediated NK cell activation and proliferation through CD16A and CD137, with potential therapeutic applications in cancer.

Journal for ImmunoTherapy of Cancer · Jul 1, 2024Peer-reviewedImmunology